FDA Inspection
Signature Formulations, LLCSignature Formulations, LLC – FDA Inspection, Jul 29, 2025
Record Details
This FDA Inspection record concerns Signature Formulations, LLC, with an inspection on July 29, 2025, issued by the Denver District Office, covering human drugs.
View Company Profile
ID · 7dd51732-5238-461a-9b1f-ed0c6d5dc223
Inspection Facts
- Inspection number
- 1269598
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
8- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.46(c)Exhaust systems inadequate to control air contamination
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Signature Formulations, LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 22, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 30, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 19, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2017 | Not classified | Denver District Office | Drug Quality Assurance |
Other documents for Signature Formulations, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.